Acadia Pharmaceuticals (ACAD) Prepaid Assets (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly Prepaid Assets of $64.6 million for Q1 2026, up 22.57% year-over-year from $52.7 million in Q1 2025, and up 8.52% quarter-over-quarter from $59.5 million in Q4 2025.
Analysis
Acadia Pharmaceuticals (ACAD) Prepaid Assets (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $64.6 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 22.57% year-over-year to $64.6 million; the TTM figure through Mar 2026 stood at $64.6 million (up 22.57% YoY), while the FY2025 annual figure was $59.5 million, up 6.91% from the prior year.
- Prepaid Assets for Q1 2026 stood at $64.6 million, up from $59.5 million in the prior quarter.
- The five-year high for Prepaid Assets was $64.6 million in Q1 2026, with the low at $21.0 million in Q2 2022.
- The 5-year median for Prepaid Assets is $42.8 million (2024), against an average of $41.3 million.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets slipped 20.05% in 2022, then surged 92.74% in 2024.
- Acadia Pharmaceuticals' Prepaid Assets stood at $21.4 million in 2022, then jumped by 82.69% to $39.1 million in 2023, then soared by 42.44% to $55.7 million in 2024, then gained by 6.91% to $59.5 million in 2025, then rose by 8.52% to $64.6 million in 2026.
- Business Quant data shows ACAD's Prepaid Assets at $64.6 million in Q1 2026, $59.5 million in Q4 2025, and $60.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Acadia Pharmaceuticals | 4.82 Bn | 3.86 Bn | 279.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.37 Mn |
| Mar 31, 2026 | 64.60 Mn |
| Dec 31, 2025 | 59.53 Mn |
| Sep 30, 2025 | 60.87 Mn |
| Jun 30, 2025 | 52.75 Mn |
| Mar 31, 2025 | 52.70 Mn |
| Dec 31, 2024 | 55.68 Mn |
| Sep 30, 2024 | 51.55 Mn |
| Jun 30, 2024 | 46.06 Mn |
| Mar 31, 2024 | 42.76 Mn |
| Dec 31, 2023 | 39.09 Mn |
| Sep 30, 2023 | 37.95 Mn |
| Jun 30, 2023 | 23.90 Mn |
| Mar 31, 2023 | 23.63 Mn |
| Dec 31, 2022 | 21.40 Mn |
| Sep 30, 2022 | 22.99 Mn |
| Jun 30, 2022 | 20.95 Mn |
| Mar 31, 2022 | 25.76 Mn |
| Dec 31, 2021 | 23.89 Mn |
| Sep 30, 2021 | 24.62 Mn |